Volume 8 Issue 27
Published - 14:00 UTC 08:00 EST 27-Jan-2006 
Next Update - 14:00 UTC 08:00 EST 28-Jan-2006

Editor: Susan K. Boyer, RN
Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


FDA approves new treatment for gastrointestinal and kidney cancer

The Food and Drug Administration (FDA) today announced approval of Sutent (sunitinib), a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors (GIST), a rare stomach cancer, and advanced kidney cancer. Today's action marks the first time the agency has approved a new oncology product for two indications simultaneously. more  

Polycystic kidney disease: NIH and PKD Foundation launch HALT-PKD treatment trials

The National Institutes of Health (NIH) and the PKD Foundation have launched two treatment trials for autosomal dominant polycystic kidney disease (ADPKD). The common inherited disorder is characterized by cysts in the kidneys and other organs, high blood pressure, and aneurysms (bulges in blood vessels, which may burst) in the brain. Symptoms usually appear between the ages of 30 and 40 and include back and side pain and headaches. more

Researchers identify major source of muscle repair cells

In a surprising discovery with implications for treating muscular dystrophy, researchers at the University of Utah School of Medicine and other institutions have identified a major source of origin for two groups of adult cells that regulate muscle repair. more  

Weight loss improves bladder control in women with prediabetes

Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence (UI) in women with prediabetes, a condition in which blood glucose levels are higher than normal but not yet diabetic. This finding comes from a new study, published in the February issue of Diabetes Care, of women who participated in the Diabetes Prevention Program (DPP), a landmark clinical study funded by the National Institutes of Health (NIH). more

Canine cancer vaccine program shows early promise 

It wasn't publicized, other than by word of mouth, and still the University of Wisconsin-Madison School of Veterinary Medicine was overwhelmed with requests. Since 1998, the school's oncology department has been producing an anti-cancer vaccine for dogs diagnosed with melanoma. Though it is still an experimental treatment, dog owners from all over the nation have wanted to participate in the study, on the remote chance that this would help their pet. more

Vaccine provides 100 percent protection against avian flu virus in animal study  

University of Pittsburgh researchers announced they have genetically engineered an avian flu vaccine from the critical components of the deadly H5N1 virus that completely protected mice and chickens from infection. Avian flu has devastated bird populations in Southeast Asia and Europe and so far has killed more than 80 people. more

BRCA1 gene found to inhibit two sex hormones, not just one

It's been known that the breast cancer susceptibility gene BRCA1 regulates use of estrogen in breast and other cells, but now researchers at Georgetown University Medical Center have discovered that it also controls activity of a second sex steroid hormone, progesterone. more

 

The FDA has approved Sutent (sunitinib), a new anti-cancer treatment for patients with gastrointestinal stromal tumors (GIST) and advanced kidney cancer.